Cidara Therapeutics, Inc.
CDTX
Kedudukan dalam Saham
#3186
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Harga Saham
$221.38
Disegerakkan terakhir: 2026-01-08
Modal Pasaran
$5.61B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
118.07%
Negara
US
Perdagangan Cidara Therapeutics, Inc. (CDTX)
Kategori
Healthcare
Sejarah pecahan saham untuk Cidara Therapeutics, Inc. (CDTX)
Saham Cidara Therapeutics, Inc. (simbol: CDTX) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Apr 24, 2024.
Satu saham CDTX yang dibeli sebelum Apr 24, 2024 kini bersamaan dengan 0.05 saham CDTX.
Pecahan saham terkini berlaku pada Apr 24, 2024.
Satu saham CDTX yang dibeli sebelum Apr 24, 2024 kini bersamaan dengan 0.05 saham CDTX.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2024-04-24 | 1:20 | x0.05 | x0.05 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|